Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AIDS pain treatment with antidepressants/anticonvulsants recommended in Franco-American guidelines.

Executive Summary

ANTIDEPRESSANTS/ANTICONVULSANTS RECOMMENDED FOR NEUROPATHIC AIDS PAIN of mild-to-moderate intensity with the addition of opioids to control residual pain, according to guidelines for pain control in HIV/AIDS patients being published by the Washington, D.C.-based France-USA Pain Association. "If pain reflects a neuropathic process and is of mild to moderate intensity, then an antidepressant and/or anticonvulsant should be started and titrated according to symptom control and side effects; later addition of an opioid should be considered if necessary to control residual pain," the document states.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026145

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel